Close

Gilead Sciences (GILD) Announces Topline Selonsertib Phase 2 Data in NASH; Anti-Fibrotic Activity Noted

Go back to Gilead Sciences (GILD) Announces Topline Selonsertib Phase 2 Data in NASH; Anti-Fibrotic Activity Noted
Gilead Sciences (NASDAQ: GILD) Delayed: 73.25 +0.24 (0.33%)
Previous Close $73.01    52 Week High $108.63 
Open $73.25    52 Week Low $71.39 
Day High $73.87    P/E 40.47 
Day Low $73.20    EPS $1.81 
Volume 8,369,725